Nicholas DeVito, MD
Duke University Medical Center
Dr. Nicholas DeVito has a strong interest in the development of immunotherapies and vaccines in the field of oncology, as well as improving the care of cancer patients. His research focuses on translational immunotherapies for solid tumors and is working to better understand the tumor immune microenvironment and immune evasion mechanisms in melanoma, non-small cell lung cancer and other malignancies. These strategies could be therapeutically targeted to enhance patient's benefits to immune checkpoint inhibitor therapy.